Aspirin Improves Survival for CRC With PIK3CA Mutation

Share this content:
Aspirin Improves Survival for CRC With <i>PIK3CA</i> Mutation
Aspirin Improves Survival for CRC With PIK3CA Mutation

(HealthDay News) -- Among patients with colorectal cancer (CRC), regular use of aspirin after diagnosis is associated with longer survival for those with the mutated phosphatidylinositol-4,5-bisphosphonate 3-kinase, catalytic subunit alpha polypeptide gene (PIK3CA), according to a study published in the Oct. 25 issue of the New England Journal of Medicine.

Xiaoyun Liao, M.D., Ph.D., from the Dana-Farber Cancer Institute in Boston, and colleagues analyzed data for 964 patients with rectal or colon cancer participating in the Nurses' Health Study and the Health Professionals Follow-up Study, including data on aspirin use after diagnosis and PIK3CA mutation status.

Among patients with mutated-PIK3CA CRCs, the researchers found that regular use of aspirin after diagnosis correlated with significantly improved CRC-specific survival (multivariate hazard ratio [HR] for cancer-related death, 0.18) and overall survival (multivariate HR for death from any cause, 0.54). Among patients with wild-type PIK3CA cancers, there was no correlation for regular use of aspirin after diagnosis with CRC-specific survival (multivariate HR, 0.96; 95 percent confidence interval [CI], 0.69 to 1.32) or overall survival (multivariate HR, 0.94; 95 percent CI, 0.75 to 1.17).

"Regular use of aspirin after diagnosis was associated with longer survival among patients with mutated-PIK3CA CRC, but not among patients with wild-type PIK3CA cancer," the authors write. "The findings from this molecular pathological epidemiology study suggest that the PIK3CA mutation in CRC may serve as a predictive molecular biomarker for adjuvant aspirin therapy."

One author disclosed financial ties to several pharmaceutical companies.

Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs